Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis
about
The genomes of four tapeworm species reveal adaptations to parasitismCrystal structure of mitochondrial quinol-fumarate reductase from the parasitic nematode Ascaris suumA transcriptomic analysis of Echinococcus granulosus larval stages: implications for parasite biology and host adaptationIn Vitro Anti-Echinococcal and Metabolic Effects of Metformin Involve Activation of AMP-Activated Protein Kinase in Larval Stages of Echinococcus granulosusThe Open Form Inducer Approach for Structure-Based Drug Design.Extensive frameshift at all AGG and CCC codons in the mitochondrial cytochrome c oxidase subunit 1 gene of Perkinsus marinus (Alveolata; Dinoflagellata).Reflections on the biochemistry of Echinococcus: past, present and future.Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes.Knockdown of the coenzyme Q synthesis gene Smed-dlp1 affects planarian regeneration and tissue homeostasis.Structural Insights into the Molecular Design of Flutolanil Derivatives Targeted for Fumarate Respiration of Parasite Mitochondria.Metabolic flexibility of mitochondrial respiratory chain disorders predicted by computer modelling.Crystallization of mitochondrial rhodoquinol-fumarate reductase from the parasitic nematode Ascaris suum with the specific inhibitor flutolanilDevelopment of spin-labeled pargyline analogues as specific inhibitors of human monoamine oxidases A and B.The ArcBA two-component system of Escherichia coli is regulated by the redox state of both the ubiquinone and the menaquinone pool.Enhanced succinic acid productivity by expression of mgtCB gene in Escherichia coli mutant.Selective Cytotoxicity of Dihydroorotate Dehydrogenase Inhibitors to Human Cancer Cells Under Hypoxia and Nutrient-Deprived Conditions
P2860
Q22122155-017B7B64-FA05-48AA-81BA-09F98405DA4FQ27679021-6E3479B2-4849-41B8-BBDE-546B58C048C0Q28485374-FF7A1A2A-80D1-42DB-8B1D-77FDF99F5AA5Q28547202-2915DC48-5FD4-4500-8817-5A7E7E936C58Q28554455-74DAAC78-A8C9-43CF-92E6-2B261AFD6937Q34189315-9FA32D38-F8AE-49B8-89D7-AEF983F64FBDQ37403847-F2F44F6D-522E-443A-8D0D-6CEB68BFAEC4Q37599990-75488DE2-1BEA-4797-B9E7-A47B684C3F29Q40375633-6C96436C-8B88-4295-BEA9-096AE65376C3Q41763256-4AFDA542-12FF-474F-992E-1CBCD6B23F80Q41840468-A9C9C49F-3DA7-4AAF-9E0B-3BD809F64F2DQ41953091-1F9453F1-BD89-4F29-82D5-0C9F203A5321Q42016555-D44851C9-01BC-436E-B08A-6DA518017AC5Q42096565-942F8B96-C005-4756-A1AF-D35229DAC31AQ51587547-E14F911B-2324-4087-9499-80E65B139CB6Q58764792-266CA12D-5FF6-4505-BFAD-965B6FE08CA5
P2860
Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Anaerobic NADH-fumarate reduct ...... apy of alveolar echinococcosis
@en
type
label
Anaerobic NADH-fumarate reduct ...... apy of alveolar echinococcosis
@en
prefLabel
Anaerobic NADH-fumarate reduct ...... apy of alveolar echinococcosis
@en
P2093
P2860
P356
P1476
Anaerobic NADH-fumarate reduct ...... apy of alveolar echinococcosis
@en
P2093
Hideto Miyoshi
Ken Katakura
Kimitoshi Sakamoto
Kinpei Yagi
Nao Yamamoto
Nariaki Nonaka
Noriko Shinjyo
Yasutoshi Kido
Yuzaburo Oku
P2860
P304
P356
10.1128/AAC.00378-07
P407
P577
2007-10-22T00:00:00Z